AbbVie (NY:ABBV)

263.43 +0.61 (+0.23%)

Delayed Quote Updated: 12:38 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Why AbbVie Stock Flopped on Friday ↗

November 01, 2025

The market didn't exactly greet the company's latest earnings release with open arms.

Via The Motley Fool

Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout

October 31, 2025

Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...

Via MarketMinute

Topics Intellectual Property

Exploring the top movers within the S&P500 index during today's session. ↗

October 31, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

Looking Into AbbVie Inc's Recent Short Interest ↗

October 31, 2025

Via Benzinga

AbbVie's Earnings Outlook ↗

October 30, 2025

Via Benzinga

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

Discover which S&P500 stocks are making waves on Friday. ↗

October 31, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗

October 31, 2025

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.

Via Benzinga

Why AbbVie (ABBV) Shares Are Falling Today

October 31, 2025

Shares of pharmaceutical company AbbVie (NYSE:ABBV) fell 3.9% in the afternoon session after the company reported third-quarter results that were overshadowed by a steep drop in profitability and a...

Via StockStory

Topics World Trade

AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend ↗

October 31, 2025

AbbVie beats Q3 estimates with $15.78 billion revenue, boosts dividend to $1.73, raises earnings outlook on strong drug portfolio growth.

Via Benzinga

Gapping S&P500 stocks in Friday's session ↗

October 31, 2025

Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

AbbVie Q3 2025 Earnings Call Transcript ↗

October 31, 2025

AbbVie Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Economy

ABBVIE INC (NYSE:ABBV) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss ↗

October 31, 2025

AbbVie's Q3 2025 results show a mixed quarter with adjusted EPS beating estimates, but revenue missed and GAAP profit fell sharply.

Via Chartmill

AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47% ↗

October 31, 2025

AbbVie stock dipped early Friday, though the drug giant easily beat views.

Via Investor's Business Daily

AbbVie’s (NYSE:ABBV) Q3 Sales Beat Estimates

October 31, 2025

Pharmaceutical company AbbVie (NYSE:ABBV) announced better-than-expected revenue in Q3 CY2025, with sales up 9.1% year on year to $15.78 billion. Its non-GAAP profit of $1.86 per share was 4.2% above...

Via StockStory

Topics Earnings

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Topics ETFs

Railway Pension Liquidates All 1.65M CCJ Shares Worth $122.8 Million ↗

October 30, 2025

Railway Pension Liquidates All 1.65M CCJ Shares Worth $122.8 Million

Via The Motley Fool

Topics Supply Chain

AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect

October 29, 2025

Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting results this Friday before market open. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. ↗

October 28, 2025

This ETF is one of the easiest ways to generate consistent passive income.

Via The Motley Fool

Topics ETFs Regulatory Compliance Stocks

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? ↗

October 28, 2025

Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker.

Via The Motley Fool

Topics Intellectual Property

October 28, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade ↗

October 26, 2025

Between growth and dividends, these companies have plenty to offer.

Via The Motley Fool

Topics Economy Intellectual Property

Retail Investors' Top Stocks With Earnings This Week: SoFi, Apple, Meta And More ↗

October 27, 2025

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites.

Via Benzinga

ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop ↗

October 23, 2025

ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop

Via The Motley Fool

Topics Energy Regulatory Compliance

Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally ↗

October 23, 2025

Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally

Via The Motley Fool

AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth ↗

October 23, 2025

AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth

Via The Motley Fool

Topics Regulatory Compliance

3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years ↗

October 23, 2025

Via MarketBeat

Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock ↗

October 23, 2025

Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock

Via The Motley Fool

Topics Economy Regulatory Compliance

Blue Owl Capital Stock Trimmed by Investment Manager, According to Recent Filing ↗

October 23, 2025

Blue Owl Capital Stock Trimmed by Investment Manager, According to Recent Filing

Via The Motley Fool

Topics Regulatory Compliance

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.